TROG Cancer Research
Members Login   CQMS Login

Subspecialty Working Parties

The primary role of the Breast, Genitourinary, Lung and Head, Neck and Skin working parties is to advise the TROG Scientific Committee (TSC) on current trials and projects in the subspecialty research portfolio, on any gaps in research activities, on new research concepts including the scientific merit of the proposal and on the research priorities to be adopted by TROG. Please see the Working Party Terms of Reference for more detailed information.

The Subspecialty Working Parties will represent radiation oncology, medical physics, radiation therapy, statistics, consumers and other appropriate disciplines (e.g. medical oncology, allied health).

If you are interested in join a working party group please complete an Expression of Interest form.   


Breast Working Party

Chair: Boon Chua

Group contact:
Tamica Humby

TROG Central Office
Phone: +61 2 4014 3905
Email: Tamica.Humby@trog.com.au


Genitourinary Working Party

Chair: David Pryor 

Group contact:
Courtney Hill
TROG Central Office
Phone: +61 2 4014 3911
Email: Courtney.Hill@TROG.com.au


Head, Neck and Skin Working Party

Chair: June Corry

Group contact:
Patrick Wheeler
TROG Central Office
Phone: +61 2 4014 3903
Email: patrick.wheeler@trog.com.au


Lung Working Party

Chair: Fiona Hegi-Johnson

Group contact:
Brita Lehmann
TROG Central Office
Phone: +61 2 4014 3912
Email: Brita.Lehmann@trog.com.au
 

 

Become a TROG member and join our community of over 1,000 health professionals.


Latest News

  • 12 Feb 2019

    a new clinical trial by trog cancer research has shown for the first time that a new radiotherapy technique produced greater survival rates in early stage inoperable lung cancer patients, compared to conventional radiation treatment. the trog 09.02 chisel study aimed to investigate if...

  • 29 Jan 2019

    results from australia’s and new zealand’s biggest cancer trial have identified the best treatment regime for men suffering from newly-diagnosed aggressive but localised prostate cancer. the radar study, run through trog cancer research, compared the use of hormone treatment (longer v...

  • 07 Aug 2018

    trog cancer research has been successful in being awarded a $1.5 million grant (2018-2020) under the cancer australia support for cancer clinical trials program. the funding from cancer australia provides essential infrastructure for trog to build our capacity to undertake cancer...

  • 07 Aug 2018

    the board of trog cancer research is pleased to announce the appointment of susan goode as the new trog chief executive officer. susan is formerly the centre manager for the hunter cancer research alliance at the university of newcastle. in this role, she was key player in a strate...

  • 16 May 2018

    the inaugural trog trek has raised more than $10,000 for trog's cancer clinical trials. the group of volunteers took on a five-day 50 kilometre trek in the spectacular bay of fires region in north east tasmania in march. each of the team members either held fundraising events or...

  • 16 May 2018

    p style="font-variant-ligatures: normal;font-variant-caps: normal;orphans: 2; text-align:start;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-style: initial; text-decoration-color: initial;word-spacing:0px">span style="font-size:11.0pt; font-family:">trog board presid...

  • 16 May 2018

    more than 270 people attended the trog 2018 annual scientific meeting (asm) in hobart, tasmania from 19-22 march. the asm was the 30th for trog and attendees included oncologists, radiation therapists, physicists, study coordinators and data managers. delegates heard from a host of...